| Aruna Tokas, MD | |
|
407 East Ave Ste 250, Pawtucket, RI 02860-5299 | |
| (401) 606-1620 | |
| Not Available |
| Full Name | Aruna Tokas |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 12 Years |
| Location | 407 East Ave Ste 250, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578970281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 260720 (Massachusetts) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | MD17033 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
| Rhode Island Hospital | 8921900044 | 303 |
News Archive
There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step toward developing a pharmaceutical treatment for the as-yet untreatable disease.
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills, fatigue, and weight loss.
The pandemic COVID-19 has affected more than 825,000 people in the US, but the daily number of new cases and deaths is not precise. A new study published on the preprint server medRxiv in April 2020 reports that Internet search interest could be used as a means to predict the daily incidence of cases in the US, as was proved in China.
As we get beyond retirement age, most of us will not be as mentally sharp as we once were. But a researcher at the University of Alberta says most people have the ability to reverse the mental declines that come with aging.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
› Verified 5 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step toward developing a pharmaceutical treatment for the as-yet untreatable disease.
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills, fatigue, and weight loss.
The pandemic COVID-19 has affected more than 825,000 people in the US, but the daily number of new cases and deaths is not precise. A new study published on the preprint server medRxiv in April 2020 reports that Internet search interest could be used as a means to predict the daily incidence of cases in the US, as was proved in China.
As we get beyond retirement age, most of us will not be as mentally sharp as we once were. But a researcher at the University of Alberta says most people have the ability to reverse the mental declines that come with aging.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
› Verified 5 days ago
| Entity Name | Rhode Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154537520 PECOS PAC ID: 8921900044 Enrollment ID: O20141017000105 |
News Archive
There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step toward developing a pharmaceutical treatment for the as-yet untreatable disease.
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills, fatigue, and weight loss.
The pandemic COVID-19 has affected more than 825,000 people in the US, but the daily number of new cases and deaths is not precise. A new study published on the preprint server medRxiv in April 2020 reports that Internet search interest could be used as a means to predict the daily incidence of cases in the US, as was proved in China.
As we get beyond retirement age, most of us will not be as mentally sharp as we once were. But a researcher at the University of Alberta says most people have the ability to reverse the mental declines that come with aging.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aruna Tokas, MD 117 Ellenfield St Ste 101, Providence, RI 02905-4541 Ph: (401) 444-6779 | Aruna Tokas, MD 407 East Ave Ste 250, Pawtucket, RI 02860-5299 Ph: (401) 606-1620 |
News Archive
There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step toward developing a pharmaceutical treatment for the as-yet untreatable disease.
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills, fatigue, and weight loss.
The pandemic COVID-19 has affected more than 825,000 people in the US, but the daily number of new cases and deaths is not precise. A new study published on the preprint server medRxiv in April 2020 reports that Internet search interest could be used as a means to predict the daily incidence of cases in the US, as was proved in China.
As we get beyond retirement age, most of us will not be as mentally sharp as we once were. But a researcher at the University of Alberta says most people have the ability to reverse the mental declines that come with aging.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
› Verified 5 days ago
Mahmoud Mowafy, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2258 Fax: 401-729-3343 | |
Mriganka Singh, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 407 East Ave, Suite 110, Pawtucket, RI 02860 Phone: 401-728-7270 | |
Amber Gul, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 333 School St, Suite 210, Pawtucket, RI 02860 Phone: 401-726-9790 Fax: 401-728-8606 | |
Dr. Madhavi Yerneni, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 407 East Ave, Suite 120, Pawtucket, RI 02860 Phone: 401-725-4700 Fax: 401-725-4740 | |
Waseem Barham, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2221 Fax: 401-729-2202 | |
Jaleh Fallah, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 111 Brewster St, Pawtucket, RI 02860 Phone: 401-729-2258 Fax: 401-729-3343 | |
Abraham Walusimbi, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster Street, Pawtucket, RI 02860 Phone: 401-729-2258 Fax: 401-729-3343 |